Best Practices, Strategies & Use of Novel Biological Responses for Robust Cell-Based Potency Assays

News
Article

Sponsored Content

Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics.

Related Content
Site Logo

Selecting container closure components with confidence: A data-driven approach to container closure integrity

West Pharmaceutical Services
June 13th 2025
Article

Drug products in development require compatible packaging to meet milestones and gain approval. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.

Site Logo

Nasal Delivery of Spray Dried Biologics: Opportunities & Challenges

Upperton Pharma Solutions
June 13th 2025
Article

Site Logo

Characterisation of Spray Dried Biologics

Upperton Pharma Solutions
June 13th 2025
Article

Site Logo

Spray Drying Biologics: An Alternative to Freeze Drying

Upperton Pharma Solutions
June 13th 2025
Article

Site Logo

Pharmaceutical Spray Drying: Technology and Applications

Upperton Pharma Solutions
June 13th 2025
Article

Site Logo

Novel Cell Lysis Solution: Scaling up viral vector harvest with ease and regulatory compliance

Avantor
June 4th 2025
Article